Erythropoietin facilitates resuscitation from ventricular fibrillation by signaling protection of mitochondrial bioenergetic function in rats

American Journal of Translational Research

Volumn 5, Issue 3, 2013, Pages 316-326

  Radhakrishnan, Jeejabai ^a   Upadhyaya, Madhav P ^b   Ng, Matthew ^b   Edelheit, Ari ^b   Moy, Hawnyeu M ^b   Ayoub, Iyad M ^a   Gazmuri, Raúl J ^a,c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c Captain James A Lovell Federal Health Care Center   (United States)

Author keywords

Cardiopulmonary resuscitation; Erythropoietin; Mitochondrial function; Myocardial function; Rats; Ventricular fibrillation

Indexed keywords

CYTOCHROME C OXIDASE; DOBUTAMINE; ERYTHROPOIETIN; PROTEIN KINASE B; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CARDIAC WORK INDEX; CELL FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE SPECIFIC SURVIVAL; HEART FUNCTION; HEART HEMODYNAMICS; HEART MITOCHONDRION; HEART VENTRICLE FIBRILLATION; KAPLAN MEIER METHOD; MALE; MEAN AORTIC PRESSURE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT; RESUSCITATION; WESTERN BLOTTING;

RATTUS;

EID: 84877012446     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 1998; 95: 4635-4640.
2. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505.
3. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 2003; 100: 4802-4806.
4. Hu L, Yang C, Zhao T, Xu M, Tang Q, Yang B, Rong R, Zhu T. Erythropoietin Ameliorates Renal Ischemia and Reperfusion Injury via Inhibiting Tubulointerstitial Inflammation. J Surg Res 2012; 176: 260-266.
5. Singh D, Kolarova JD, Wang S, Ayoub IM, Gazmuri RJ. Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation. Am J Ther 2007; 14: 361-368.
6. Kolarova JD, Ayoub IM, Gazmuri RJ. Cariporide enables hemodynamically more effective chest compression by leftward shift of its flowdepth relationship. Am J Physiol Heart Circ Physiol 2005; 288: H2904-H2911.
7. Ayoub IM, Kolarova J, Kantola R, Radhakrishnan J, Gazmuri RJ. Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes post-resuscitation myocardial dysfunction through benefits on energy metabolism. Crit Care Med 2007; 35: 2329-2336.
8. Grmec S, Strnad M, Kupnik D, Sinkovic A, Gazmuri RJ. Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation 2009; 80: 631-637.
9. Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, Murphy E. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J 2005; 19: 1323-1325.
10. Cai Z and Semenza GL. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 2004; 109: 2050-2053.
11. Shi Y, Rafiee P, Su J, Pritchard KA Jr, Tweddell JS, Baker JE. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 2004; 99: 173-182.
12. Radhakrishnan J, Kolarova JD, Ayoub IM, Gazmuri RJ. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest. Transl Res 2011; 157: 71-80.
13. Radhakrishnan J, Wang S, Ayoub IM, Kolarova JD, Levine RF, Gazmuri RJ. Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol 2007; 292: H767-H775
14. Sharma SK and Carew TJ. Inclusion of phosphatase inhibitors during Western blotting enhances signal detection with phospho-specific antibodies. Anal Biochem 2002; 307: 187-189.
15. Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, van den Heuvel LP, Wintjes LT, Stoltenborg-Hogenkamp BJ, Rodenburg RJ. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 2007; 53: 729-734.
16. Jarreta D, Orus J, Barrientos A, Miro O, Roig E, Heras M, Moraes CT, Cardellach F, Casademont J. Mitochondrial function in heart musclefrom patients with idiopathic dilated cardiomy opathy. Cardiovasc Res 2000; 45: 860-865.
17. Tzagoloff A. Oligomycin-sensitive ATPase of Saccharomyces cerevisiae. Methods Enzymol 1979; 55: 351-358.
18. Mueller DM. Arginine 328 of the beta-subunit of the mitochondrial ATPase in yeast is essential for protein stability. J Biol Chem 1988; 263: 5634-5639.
19. King EJ. The colorimetric determination of phosphorus. Biochem J 1932; 26: 292-297.
20. Gazmuri RJ, Weil MH, Bisera J, Tang W, Fukui M, McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996; 24: 992-1000.
21. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning. J Am Coll Cardiol 1996; 28: 232-240.
22. Tojo A, Doumoto M, Oka K, Numabe A, Kimura K, Yagi S. Endothelin-mediated effect of erythropoietin on blood pressure and renal hemodynamics in hypertensive rats. Am J Physiol 1996; 270: R744-R748.
23. Laurent I, Monchi M, Chiche JD, Joly LM, Spaulding C, Bourgeois B, Cariou A, Rozenberg A, Carli P, Weber S, Dhainaut JF. Reversible myocardial dysfunction in survivors of out-ofhospital cardiac arrest. J Am Coll Cardiol 2002; 40: 2110-2116.
24. Kern KB, Hilwig RW, Berg RA, Rhee KH, Sanders AB, Otto CW, Ewy GA. Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 1997; 95: 2610-2613.
25. Prabu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, Avadhani NG. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 2006; 281: 2061-2070.
26. Corbucci GG, Perrino C, Donato G, Ricchi A, Lettieri B, Troncone G, Indolfi C, Chiariello M, Avvedimento EV. Transient and reversible deoxyribonucleic acid damage in human left ven tricle under controlled ischemia and reperfu sion. J Am Coll Cardiol 2004; 43: 1992-1999.
27. Dawson TL, Gores GJ, Nieminen AL, Herman B, Lemasters JJ. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol 1993; 264: C961-C967.
28. Guo D, Nguyen T, Ogbi M, Tawfik H, Ma G, Yu Q, Caldwell RW, Johnson JA. Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol 2007; 293: H2219-H2230